Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 4
2004 4
2006 4
2007 2
2008 4
2009 6
2010 1
2011 3
2012 5
2013 7
2014 13
2015 18
2016 19
2017 35
2018 41
2019 43
2020 44
2021 41
2022 31
2023 30
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year

Filters applied: . Clear all
Page 1
Current epidemiology in hepatocellular carcinoma.
Konyn P, Ahmed A, Kim D. Konyn P, et al. Among authors: ahmed a. Expert Rev Gastroenterol Hepatol. 2021 Nov;15(11):1295-1307. doi: 10.1080/17474124.2021.1991792. Epub 2021 Oct 22. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34624198 Review.
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey JN, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C. Benson AB, et al. Among authors: ahmed a. J Natl Compr Canc Netw. 2023 Jul;21(7):694-704. doi: 10.6004/jnccn.2023.0035. J Natl Compr Canc Netw. 2023. PMID: 37433432
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ; REGENERATE Study Investigators. Younossi ZM, et al. Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5. Lancet. 2019. PMID: 31813633 Free article. Clinical Trial.
Kim D, Konyn P, Ahmed A. Kim D, et al. Among authors: ahmed a. Clin Gastroenterol Hepatol. 2023 Apr;21(4):1123-1124. doi: 10.1016/j.cgh.2022.08.002. Epub 2022 Aug 11. Clin Gastroenterol Hepatol. 2023. PMID: 35963540 No abstract available.
The Reply.
Yeoh A, Cheung R, Ahmed A, Chitnis AS, Do A, Wong RJ. Yeoh A, et al. Among authors: ahmed a. Am J Med. 2024 Jan;137(1):e15. doi: 10.1016/j.amjmed.2023.08.024. Am J Med. 2024. PMID: 38061829 No abstract available.
Ahmed A, Beckerman R, Younossi ZM. Ahmed A, et al. Hepatology. 2018 Jan;67(1):450-451. doi: 10.1002/hep.29555. Hepatology. 2018. PMID: 28960407 No abstract available.
307 results